Trial · NCT00474240
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in LDL-C at 8 Weeks | Placebo | 2 | Standard Deviation 11.2 | Percent Change | |
| Percent Change From Baseline in LDL-C at 8 Weeks | Atorvastatin 20 mg | -42 | Standard Deviation 16.4 | Percent Change | |
| Percent Change From Baseline in LDL-C at 8 Weeks | AEGR-733 5 mg | -16 | Standard Deviation 17.3 | Percent Change | |
| Percent Change From Baseline in LDL-C at 8 Weeks | AEGR-733 10 mg | -37 | Standard Deviation 23.0 | Percent Change | |
| Percent Change From Baseline in LDL-C at 8 Weeks | AEGR-733 5 mg + Atorvastatin 20 mg | -47 | Standard Deviation 19.2 | Percent Change | |
| Percent Change From Baseline in LDL-C at 8 Weeks | AEGR-733 10 mg + Atorvastatin 20 mg | -50 | Standard Deviation 28.0 | Percent Change | |
| Percent Change From Baseline of Other Lipids | Placebo | Percent change from baseline in total cholesterol | 2 | Standard Deviation 9.9 | Percent |
| Percent Change From Baseline of Other Lipids | Atorvastatin 20 mg | Percent change from baseline in total cholesterol | -30 | Standard Deviation 12.4 | Percent |
| Percent Change From Baseline of Other Lipids | AEGR-733 5 mg | Percent change from baseline in total cholesterol | -18 | Standard Deviation 14.6 | Percent |
| Percent Change From Baseline of Other Lipids | AEGR-733 10 mg | Percent change from baseline in total cholesterol | -33 | Standard Deviation 19.0 | Percent |
| Percent Change From Baseline of Other Lipids | AEGR-733 5 mg + Atorvastatin 20 mg | Percent change from baseline in total cholesterol | -37 | Standard Deviation 15.3 | Percent |
| Percent Change From Baseline of Other Lipids | AEGR-733 10 mg + Atorvastatin 20 mg | Percent change from baseline in total cholesterol | -40 | Standard Deviation 20.7 | Percent |
| Percent Change From Baseline of Other Lipids | Placebo | Percent change from baseline in total Apo B | 0 | Standard Deviation 11.0 | Percent |
| Percent Change From Baseline of Other Lipids | Atorvastatin 20 mg | Percent change from baseline in total Apo B | -34 | Standard Deviation 13.0 | Percent |
| Percent Change From Baseline of Other Lipids | AEGR-733 5 mg | Percent change from baseline in total Apo B | -17 | Standard Deviation 12.4 | Percent |
| Percent Change From Baseline of Other Lipids | AEGR-733 10 mg | Percent change from baseline in total Apo B | -36 | Standard Deviation 21.9 | Percent |
| Percent Change From Baseline of Other Lipids | AEGR-733 5 mg + Atorvastatin 20 mg | Percent change from baseline in total Apo B | -41 | Standard Deviation 16.9 | Percent |
| Percent Change From Baseline of Other Lipids | AEGR-733 10 mg + Atorvastatin 20 mg | Percent change from baseline in total Apo B | -46 | Standard Deviation 19.8 | Percent |
| Percent Change From Baseline of Other Lipids | Placebo | Percent change from baseline in non-HDL-C | 2 | Standard Deviation 10.3 | Percent |
| Percent Change From Baseline of Other Lipids | Atorvastatin 20 mg | Percent change from baseline in non-HDL-C | -38 | Standard Deviation 15.8 | Percent |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00474240/results